Unveiling the surgical risk associated with neoadjuvant chemotherapy in bladder cancer
Student Authors
William Martin-DoyleFaculty Advisor
Joaquim Bellmunt (Dana Farber)Document Type
Response or CommentPublication Date
2014-08-01Keywords
Antineoplastic AgentsCystectomy
Female
Humans
Male
Neoadjuvant Therapy
Urinary Bladder Neoplasms
Neoplasms
Therapeutics
Urology
Metadata
Show full item recordAbstract
William Martin-Doyle participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School.Source
BJU Int. 2014 Aug;114(2):163-4. doi: 10.1111/bju.12661. Link to article on publisher's siteDOI
10.1111/bju.12661Permanent Link to this Item
http://hdl.handle.net/20.500.14038/49273PubMed ID
25070136Notes
William Martin-Doyle participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School.
Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1111/bju.12661